Volume 10, Number 2—February 2004
THEME ISSUE
2004 SARS Edition
SARS Transmission
SARS-associated Coronavirus Transmission, United States
Table 1
Specimen type | No. of specimens (no. of case-patients) by no. of days after illness onset |
Total no. of specimens | ||
---|---|---|---|---|
0–14 days | 15–28 days | >28 days | ||
Respiratory | 11 (7) | 12 (4) | 18 (7) | 41 |
Sputum | 2 (2) | 2 (1) | 0 (0) | 4 |
NP swab | 5 (5) | 4 (4) | 9 (6) | 18 |
OP swab | 2 (2) | 6 (4) | 9 (7) | 17 |
Nasal aspirate | 1 (1) | 0 (0) | 0 (0) | 1 |
Nasal wash | 1 (1) | 0 (0) | 0 (0) | 1 |
Stool | 1 (1) | 5 (2) | 8 (6) | 14 |
Urine | 0 | 2 (2) | 6 (5) | 8 |
Serum/blood | 18 (7) | 15 (4) | 15 (7) | 48 |
aSARS, severe acute respiratory syndrome; NP, nasopharyngeal; OP, oropharyngeal.
1Members of the SARS Investigation Group: J. McLaughlin (Alaska Division of Health); M. Romney, A. Kimura (California Department of Health Services); D. Dassey, B. Lash, D. Terashita (California-Los Angeles County Health Department); S. Klish (California-Orange County Health Care Agency); S. Cody (California-Santa Clara County Health Department); S. Farley (California-Contra County Health Department); S. Lea (California-Marin County Health Department); R. Sanderson (Florida Department of Health); J. Wolthuis (Georgia Division of Public Health); C. Allard (Mississippi Department of Health); B. Albanese (New Mexico Department of Health); B. Nivin (New York City Department of Health and Mental Hygiene); P. McCall, M. Davies (North Carolina Department of Health); M. Murphy, E. Koch (Ohio Department of Health); A. Weltman (Pennsylvania Department of Health); H. Brumund (Virginia Department of Health); C. Barton (Utah Department of Health); K. Whetstone (Southwest Utah Public Health Department); W. J. Bellini, S. Bialek, J. A. Comer, S. Emery, R. Helfand, T. Hennessy, A. James, A. LaMonte, E. C. Newbern, S. Scott, L. Simpson, A. Siwek, C. Smelser, L. Stockman, X. Lu, D. White (Centers for Disease Control and Prevention).